Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,949 | -1,488 | -9,802 | -542 | -675 |
| Depreciation Amortization | 33 | 55 | 276 | 227 | 335 |
| Other Working Capital | 447 | 445 | 221 | 2 | 13 |
| Other Operating Activity | 1,263 | 662 | 8,553 | 73 | 67 |
| Operating Cash Flow | $-206 | $-327 | $-751 | $-240 | $-260 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -2 | N/A |
| Investing Cash Flow | $N/A | $N/A | $0 | $-2 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 59 | 29 | 95 | 222 | 269 |
| Debt Repayment | -6 | -17 | N/A | N/A | N/A |
| Common Stock Issued | 73 | 5 | 500 | 1 | N/A |
| Other Financing Activity | 73 | 310 | 81 | 0 | 0 |
| Financing Cash Flow | $199 | $327 | $676 | $223 | $269 |
| Beginning Cash Position | 6 | 6 | 81 | 101 | 92 |
| End Cash Position | 0 | 6 | 6 | 81 | 101 |
| Net Cash Flow | $-6 | $0 | $-76 | $-19 | $9 |
| Free Cash Flow | |||||
| Operating Cash Flow | -206 | -327 | -751 | -240 | -260 |
| Capital Expenditure | N/A | N/A | N/A | -2 | N/A |
| Free Cash Flow | -206 | -327 | -751 | -242 | -260 |